Proposed Chinese Pharmaceutical Regulations Could Reform Regulation

With the government implementing more reform initiatives, the National Medical Products Administration NMPA on May 9, 2022, published new draft Implementing Regulations, which will add a total of 101 new articles to the latest version of the Law.

Related Keywords

China ,Chinese , ,Drug Administration Law ,International Council On Harmonisation ,Guiding Principles For Clinical Research ,Reform Commission ,National Medical Products Administration ,National Security ,China National Development ,Approval System ,Medical Devices ,Inspiring Innovation ,Implementing Regulations ,Draft Regulations ,State Council ,Incentivize Innovation ,Patent Law ,Marketing Authorization Holder ,Guiding Principles ,Clinical Research ,Antitumor Drugs Based ,Clinical Value ,Implementing Measures ,Trial Data ,Interim Implementation ,Drug Evaluation ,Although China ,International Council ,National Development ,Five Year Plan ,New Challenges Ahead ,Early Resolution Mechanism ,Drug Patent Disputes ,Trial Implementation ,Supreme People ,Several Issues ,Civil Dispute Cases Related ,Patent Rights Pertaining ,Administrative Decisions ,Legal ,Pharmaceutical Regulations ,Global Pharmaceutical Trade ,Tampa ,